Associate Director for Electronics Technology
Reinholz has served in various technical management capacities at the NDSU Center for Nanoscale Science & Engineering (CNSE) since 2004. He coordinates with industry partners during management of multiple project executions, leads strategic planning and marketing, and oversees engineering service centers. Reinholz previously was employed by Rockwell Collins, Inc., Cedar Rapids, Iowa, working in various product development hardware engineering, systems engineering and project management roles.
Senior Project Manager
Noah received a bachelor's degree in electrical engineering from North Dakota State University, Fargo, in 1980 and a master's degree in electrical engineering from Stanford University in 1981. He has 26 years of experience in the field of signal processing, high-speed communication equipment design, venture capital, business formation and business hyper-growth.
Associate Vice President of Business Development & Industry Relations
Dennis Anderson, an NDSU alumnus, joined the university in the Office of Technology Transfer. Mr. Anderson then served as Director of Business Development and Industry Relations in the Office of Vice President for Research, Creative Activities, and Technology Transfer after which he was made Assistant Vice President and then Associate Vice President. He previously served as director of business development at Molecular Genetics, Inc. As director of business development and preclinical research and development for MGI PHARMA, Inc., Mr. Anderson was responsible for creation and management of all preclinical pharmacology and safety studies and trials with both private sector contract research organizations as well as leading academic health sciences centers in U.S., Europe, and Japan. He has served as vice president of regulatory affairs and technology development for Algenix, Inc., and Biovirx, Inc., both Minnesota biotech startup companies. Anderson also co-founded Biotronix, Inc., a biopharamaceutical research and development company, and OutaBox Thinking, Inc., a biopharmaceutical consulting company. Mr. Anderson's expertise includes private sector research and development of biotechnology and bio-pharmaceutical products and specialty chemicals. He had personal responsibility for creation and management of multiple INDs, IDEs, and NDAs during his tenure with the private sector. Mr. Anderson has over 25 years of experience in intellectual property management and protection, technology transfer and licensing, creation and management of entrepreneurial start-ups, and commercialization of high technologies, e.g., biotechnology, biopharmaceuticals. Mr. Anderson is especially knowledgeable in those regulatory activities related to research, development and commercialization of technologies and products that are regulated either by U.S. FDA, U.S. EPA, and USDA and EU-EMEA, particularly as applied to preclinical and clinical research, and sponsored research in corporate and academic settings.